Guidance Notes
- Guidance Note 23: Shareholder intention statements
- Guidance Note 22: Recommendations and Undervalue Statements
- Guidance Note 21: Collateral Benefits
- Guidance Note 20: Equity Derivatives
- Guidance Note 19: Insider Participation in Control Transactions
- Guidance Note 18: Takeover Documents
- Guidance Note 17: Rights issues
- Guidance Note 15: Trust scheme mergers
- Guidance Note 14: Funding Arrangements
- Guidance Note 13: Broker Handling Fees
- Guidance Note 12: Frustrating Action
- Guidance Note 11: Conflicts of Interest
- Guidance Note 7: Deal protection
- Guidance Note 6: Minimum Bid Price
- Guidance Note 5: Specific Remedies – Information Deficiencies
- Guidance Note 4: Remedies General
- Guidance Note 2: Reviewing Decisions
- Guidance Note 1: Unacceptable Circumstances